Review
Published on 03 Apr 2025
Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1524763
- 295 views
Type at least 3 characters
2,991 articles
Original Research
Published on 03 Apr 2025
Aryl hydrocarbon receptor-regulated long non-coding RNAs: implications for glycolipid metabolism and prognosis in hepatocellular carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1537481
- 175 views
Original Research
Published on 02 Apr 2025
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1556881
- 124 views
Review
Published on 02 Apr 2025
Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1519103
- 320 views
Review
Published on 01 Apr 2025
LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1552773
- 158 views
Systematic Review
Published on 31 Mar 2025
The rising influence of lipid metabolism in lung cancer: a global research perspective
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1562621
- 157 views
Review
Published on 31 Mar 2025
Liquid-liquid phase separation in cell physiology and cancer biology: recent advances and therapeutic implications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1540427
- 220 views
Mini Review
Accepted on 27 Mar 2025
A review shows that ATG10 has been identified as a potential prognostic marker and therapeutic target for cancer patients based on real-world studies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1573378
Editorial
Accepted on 27 Mar 2025
Editorial: Deciphering the Role of Signature Genes in Cancer Prognosis and Therapy Resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1591256
Review
Published on 27 Mar 2025
The NIMA-related kinase family and cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1556917
- 189 views
Original Research
Accepted on 26 Mar 2025
Examination of the Functions and Mechanism of KCP in Mediating Paclitaxel Resistance in Cervical Squamous Carcinoma Cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1550032
Original Research
Accepted on 26 Mar 2025
Single-Cell Transcriptomics and Functional Validation Revealed PLEKHA5-L as a Promoter of Growth and Migration in Brain Metastatic Melanoma Cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1560954
Original Research
Accepted on 25 Mar 2025
Overexpression of MMP14 is associated with Poor Prognosis and Immune Cell Infiltration in Colon Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1564375
Original Research
Published on 24 Mar 2025
RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1543657
- 600 views
Review
Published on 24 Mar 2025
The interrelated roles of RAB family proteins in the advancement of neoplastic growth
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1513360
- 232 views
Correction
Accepted on 21 Mar 2025
Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1558771